Biomark Diagnostics
  • Home
  • About BioMark
    • About Us
    • BioMark Technology
    • Publications & Scientific Posters
    • Awards and Achievements
    • Strategic Collaborations
    • Cancer Education Videos
  • Oncology Platform
    • Biomark SSAT1 Assay
    • BioMark Metabolic Panel
  • Investor Relations
    • Stock Quote
    • News Releases
    • Investment Highlights
    • Corporate Presentations and Communication
  • Bio-Stream Diagnostics
    • Bio-Stream Spectral Test
  • Recent Posts
  • Info & Contact

News Releases

« Back to News

BioMark Lists on Frankfurt Stock Exchange

November 26, 2014

Press Release BIOMARK LISTS ON FRANKFURT STOCK EXCHANGE – November 26, 2014 (PDF)

———————————————

< BioMark Receives the Commercialization Support for Business (CSB) Stream 1 Program Dr. Safieddin Safavi-Naeini Joins Biomark Scientific Advisory Team >

ARCHIVES

  • 2020 News Release
  • 2019 News Release
  • 2018 News Release
  • 2017 News Release
  • 2016 News Release
  • 2015 News Release
  • 2014 News Release
Further information about BioMark is available under its profile on:
SEDAR website:
http://www.sedar.com
CSE website:
http://thecse.com

Sitemap

  • Home
  • About BioMark
    • About Us
    • BioMark Technology
    • Publications & Scientific Posters
    • Awards and Achievements
    • Strategic Collaborations
    • Cancer Education Videos
  • Oncology Platform
    • Biomark SSAT1 Assay
    • BioMark Metabolic Panel
  • Investor Relations
    • Stock Quote
    • News Releases
    • Investment Highlights
    • Corporate Presentations and Communication
  • Bio-Stream Diagnostics
    • Bio-Stream Spectral Test
  • Recent Posts
  • Info & Contact

Latest Posts

  • Cancer that went undetected during the pandemic an ‘impending disaster,’ specialists warn
  • Missing cancer cases a worrying pandemic trend
  • World Cancer Day: A leading international awareness day
  • Doctors fear an impending wave of cancer patients after COVID-19 delays
  • Richmond company looking for ‘holy grail’ in COVID-19 testing

Site Policies

  • Terms and Conditions
  • Website and Privacy Policy

Contact Us

INVESTOR CORPORATE INQUIRES

RASHID A. BUX
  • CEO
  • 604.370.0779
  • info@biomarkdiagnostics.com

Copyright © 2019 BioMark Diagnostics Inc. All rights reserved.

Biomark Diagnostics

BioMark's mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.